Jonathan Fetene, MD
Hospital Resident
Research & Publications
Biography
Coauthors
Selected Publications
- Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel DiseaseSahyoun L, Fetene J, McMillan C, Protiva P, Al Bawardy B, Gaidos J, Proctor D. Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel Disease. Digestive Diseases And Sciences 2024, 1-7. PMID: 38466459, DOI: 10.1007/s10620-024-08355-3.
- FRAILTY IS ASSOCIATED WITH POOR OUTCOMES IN PATIENTS ADMITTED FOR ACUTE NECROTIZING Pancreatitis Ahmad Nawaz, Abdelkader Chaar, Rabia Rizwan, David Restrepo, Jonathan A. Fetene, Khaled Alsabbagh Alchirazi, Dania Abdulkarim, Fatima Khalid, Rushabh Doshi, Karthik Mathialagan, Kenneth W. Hung, Loren Laine, Thiruvengadam Muniraj.
- IMPACT OF OBESITY AND MORBID OBESITY ON OUTCOMES OF PATIENTS UNDERGOING ENDOSCOPIC PANCREATIC NECRESECTOMYAhmad Nawaz, Abdelkader Chaar, Rabia Rizwan, Jonathan A. Fetene, David Restrepo, Khaled Alsabbagh Alchirazi, Dania Abdulkarim, Fatima Khalid, Karthik Mathialagan, Maija Cheung, Loren Laine, Thiruvengadam Muniraj
- reaking the habit: a quality improvement project to increase the prescription and uptake of smoking cessation medications Price, C., Smith, R., Huang, J., Chan, E., & Fetene, J.
- S1000 Exploring the Influence of COVID-19 Treatment on Real-World Outcomes in IBD Patients: A Comprehensive AnalysisSahyoun L, McMillan C, Fetene J, Protiva P, Al-Bawardy B, Gaidos J, Proctor D. S1000 Exploring the Influence of COVID-19 Treatment on Real-World Outcomes in IBD Patients: A Comprehensive Analysis. The American Journal Of Gastroenterology 2023, 118: s757-s757. DOI: 10.14309/01.ajg.0000953640.32433.d2.
- Exploring the Influence of COVID-19 Treatment on Real-World Outcomes in IBD Patients: A Comprehensive AnalysisSahyoun, Laura MD1,*; McMillan, Chandler BA2; Fetene, Jonathan MD3; Protiva, Petr MD, MPH4; Al-Bawardy, Badr MD5; Gaidos, Jill MD, FACG1; Proctor, Deborah D. MD1. S1000 Exploring the Influence of COVID-19 Treatment on Real-World Outcomes in IBD Patients: A Comprehensive Analysis. The American Journal of Gastroenterology 118(10S):p S757, October 2023. | DOI: 10.14309/01.ajg.0000953640.32433.d2
- Phosphorus bioaccessibility measured in four amino acid–based formulas using in-vitro batch digestion translates well into phosphorus bioavailability in miceChande S, Dijk F, Fetene J, Yannicelli S, Carpenter TO, van Helvoort A, Bergwitz C. Phosphorus bioaccessibility measured in four amino acid–based formulas using in-vitro batch digestion translates well into phosphorus bioavailability in mice. Nutrition 2021, 89: 111291. PMID: 34111672, PMCID: PMC8588148, DOI: 10.1016/j.nut.2021.111291.
- Slc20a1/Pit1 and Slc20a2/Pit2 are essential for normal skeletal myofiber function and survivalChande S, Caballero D, Ho BB, Fetene J, Serna J, Pesta D, Nasiri A, Jurczak M, Chavkin NW, Hernando N, Giachelli CM, Wagner CA, Zeiss C, Shulman GI, Bergwitz C. Slc20a1/Pit1 and Slc20a2/Pit2 are essential for normal skeletal myofiber function and survival. Scientific Reports 2020, 10: 3069. PMID: 32080237, PMCID: PMC7033257, DOI: 10.1038/s41598-020-59430-4.
- Transgenic mouse model for conditional expression of influenza hemagglutinin-tagged human SLC20A1/PIT1Chande S, Ho B, Fetene J, Bergwitz C. Transgenic mouse model for conditional expression of influenza hemagglutinin-tagged human SLC20A1/PIT1. PLOS ONE 2019, 14: e0223052. PMID: 31613887, PMCID: PMC6793878, DOI: 10.1371/journal.pone.0223052.
- Enpp1-Fc treatment reduces renal calcifications in Npt2anull miceJonathan Fetene, Daniel Caballero, Xiaofeng Li, Dillon Kavanagh, Demetrios Braddock, Clemens Bergwitz. (2018, Nov). Enpp1-Fc treatment reduces renal calcifications in Npt2anull mice. JOURNAL OF BONE AND MINERAL RESEARCH, 33(10), 349-349.
- Enpp 1-Fc treatment reduces renal calcifications in Npt2anull miceJonathan Fetene, Daniel Caballero, Xiaofeng Li, Dillon Kavanagh, Demetrios Braddock, Clemens Bergwitz. (2018, February 19). Enpp 1-Fc treatment reduces renal calcifications in Npt2anull mice [Poster presented]. The American society of Bone and Mineral research/Vancouver, BC, CAN.
- Intraperitoneal pyrophosphate treatment reduces renal calcifications in Npt2a null miceCaballero D, Li Y, Fetene J, Ponsetto J, Chen A, Zhu C, Braddock DT, Bergwitz C. Intraperitoneal pyrophosphate treatment reduces renal calcifications in Npt2a null mice. PLOS ONE 2017, 12: e0180098. PMID: 28704395, PMCID: PMC5509111, DOI: 10.1371/journal.pone.0180098.